Question

10 year old labrador retriever is starting long term carprofen therapy for osteoarthritis. what is baseline and follow up monitoring plan for veterinary nsaid use

Answer 1

Good plan — monitoring is essential because older dogs are at higher risk for NSAID-related adverse effects (GI, renal, hepatic). Below is a practical baseline and follow‑up monitoring plan you can use for a 10‑year‑old Labrador starting long‑term carprofen.

Baseline (prior to starting)
- Complete physical exam (weight, body condition, oral cavity, abdominal palpation, hydration, neurologic status).
- Full history: concurrent drugs/supplements (esp. corticosteroids, other NSAIDs, aspirin, aminoglycosides, ACE inhibitors, diuretics), prior GI/renal/hepatic disease, anesthesia/surgery plans.
- Clinic blood pressure (especially if older or renal disease/heart disease).
- CBC (look for anemia, infection, thrombotic/bleeding risk).
- Serum biochemistry panel: focus on ALT, ALP, AST, bilirubin, albumin/total protein, BUN, creatinine, electrolytes, glucose.
- Urinalysis including USG and sediment (assess concentrating ability, proteinuria, infection).
- Consider baseline coagulation profile or imaging only if clinical indication.

Initial follow‑up schedule
- Early recheck: 7–14 days after starting therapy — physical exam and owner check for clinical signs; repeat biochemistry (especially ALT, BUN/creatinine) and urinalysis if patient is high risk or you suspect an adverse effect.
- 4 weeks: recheck physical exam + CBC, serum biochemistry, urinalysis (common practice).
- 3 months: recheck CBC/chemistry/UA and BP.

Ongoing monitoring (stable patient)
- Every 3–6 months: physical exam plus CBC, serum chem panel (liver and renal values) and urinalysis. Frequency toward 3 months is recommended for older dogs or those with borderline values; 6 months may be reasonable for healthy patients with stable tests.
- More frequent checks (monthly to every 3 months) for dogs with preexisting renal or hepatic disease, polypharmacy, or prior NSAID adverse effects.

What to watch for (owner education)
- Stop the NSAID and contact the clinic immediately if any of these occur: vomiting, diarrhea (especially bloody), black/tarry stools, decreased appetite for >24–48 h, weakness/lethargy, jaundice, increased drinking/urinating or decreased urine output, melena, or any neurologic signs.
- Give medication with food to reduce GI upset (unless specific instruction to the contrary).

Lab change action thresholds (practical guidance)
- Marked hepatic enzyme increase (ALT >3× upper reference limit or rapid increase from baseline) or clinical signs of hepatic dysfunction → discontinue NSAID and reassess (repeat labs, consider hepatoprotective/supportive care).
- Rising BUN/creatinine or falling USG (loss of concentrating ability) or clinical dehydration → discontinue NSAID, assess renal function, fluid therapy as needed.
- Any significant hematologic abnormality (new anemia, thrombocytopenia, severe leukopenia) → stop and investigate.

Drug interactions / contraindications (brief)
- Avoid concurrent systemic corticosteroids or other NSAIDs/aspirin.
- Use caution with diuretics, ACE inhibitors, aminoglycosides — monitor renal function closely.
- Reassess necessity of nephrotoxic or hepatotoxic concurrent drugs.

If abnormal findings occur
- Stop NSAID immediately. Repeat bloodwork/UA. Provide supportive care (fluids, GI protectants, antiemetics), consider hospitalization if severe. Reintroduce a different analgesic class only after full assessment and informed risk/benefit discussion.

Example quick checklist for this patient
- Before start: PE, weight, BP, CBC, chemistry (incl. ALT, BUN/creatinine), UA.
- Days 7–14: owner phone check; repeat chemistry/UA if high risk or any symptoms.
- 1 month: PE + CBC/chemistry/UA.
- Every 3 months thereafter if elderly/comorbid, or every 3–6 months if healthy and stable.

If you want, I can draft a client handout with the symptoms to watch for and the exact lab schedule tailored to this dog’s current labs/medications.